Global Health Ltd to host investors for one-to-one meets in Gurugram
- Global Health Ltd holds investor meets on September 8, 2026
- Meetings are one-to-one with Matthews International and Baillie Gifford
- Sessions occur in person at the Gurugram office
- No unpublished price-sensitive information will be shared

*this image is generated using AI for illustrative purposes only.
Global Health Limited scheduled one-to-one meetings with institutional investors and analysts for September 8, 2026. The company confirmed the engagements with Matthews International Capital Management and Baillie Gifford. Both sessions will take place in person at its Gurugram office.
Meeting Details
The management team will engage directly with the two investment firms. The schedule remains subject to change due to unforeseen circumstances.
| Date | Investor Firm | Type | Location | Mode |
|---|---|---|---|---|
| September 8, 2026 | Matthews International Capital Management | One to One | Gurugram | In person |
| September 8, 2026 | Baillie Gifford | One to One | Gurugram | In person |
Regulatory Disclosure
The company issued the intimation pursuant to Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Rahul Ranjan, Company Secretary and Compliance Officer, signed the filing dated August 31, 2026.
Global Health Limited stated that no unpublished price-sensitive information is proposed to be shared during these interactions. The notice was filed with both the BSE Limited and the National Stock Exchange of India Limited.
Historical Stock Returns for Global Health
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +0.51% | +4.97% | +5.59% | +29.94% | +5.70% | 0.0% |
How might the strategic priorities discussed with Matthews International Capital Management and Baillie Gifford influence Global Health Limited's upcoming capital allocation decisions?
What specific operational metrics or growth targets is Global Health Limited likely to emphasize to these long-term oriented investors during the in-person sessions?
Could these targeted engagements signal a broader shift in Global Health Limited's investor relations strategy towards deeper institutional partnerships in 2026?


































